Company intelligence / Profile preview

Yatai Group

Changchun, Jilin Province, Chinaen.yatai.com ↗

Ownership: Private
Development stage: Commercial

Overview

Yatai Pharmaceutical Group is one of China’s Top 100 pharmaceutical manufacturing enterprises with a vertically integrated business model covering R&D, production, distribution, and health management. It has several approved drugs including anticancer agents and vaccines; FS16 for cancer-related fatigue is in Phase II clinical trials with the FDA. The company has won national awards for innovation and science & technology progress.

Therapeutic areas: OncologyPulmonologyCardiovascularInfectious Diseases
Modalities: Small moleculeVaccineBiologic (e.g., Ginsenoside Rg3 injection)
Industry: Biotech

Beyond the preview

Go deeper on Yatai Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yatai Group.

Explore the full profile